Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?

Sodium-glucose-transporter 2 inhibitors (SGLT2i) are a new class of anti-diabetic drugs that in large trials such as CREDENCE have shown also a reduction of glomerular hyperfiltration and albuminuria in type 2 diabetic patients. Hence, the interest toward SGLT2i is focused toward this potential neph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Cupisti, Adamasco, Giannese, Domenico, Moriconi, Diego, D'Alessandro, Claudia, Torreggiani, Massimo, Piccoli, Giorgina B.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793896/
https://ncbi.nlm.nih.gov/pubmed/33425967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.622593
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados